Skip to main content

Table 4 Performance comparison among the models-Delong test

From: MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma

DeLong. Test

clinical Cox model

radiomics Cox model

Clinical+radiomics Cox model

Clinical+radiomics RSF model

clinical Cox model

/

0.797 b

0.971 b

< 0.001 b

radiomics

Cox model

0.436 a

/

0.539 b

< 0.001 b

clinical+radiomics Cox model

0.280 a

0.551 a

/

< 0.001 b

clinical+radiomics RSF model

< 0.001a

< 0.001 a

< 0.001 a

/

  1. a Training set; b Testing set